CB-5083 and p97: Bridging Protein Homeostasis and DNA Repair

Introduction

Protein homeostasis—the intricate balance between protein synthesis, folding, trafficking, and degradation—is fundamental for cellular health. Disruptions in this balance underpin the pathogenesis of cancer, neurodegeneration, and age-associated diseases. Central to these processes is the AAA ATPase p97 (valosin-containing protein, VCP), a key molecular segregase that orchestrates protein turnover and organelle maintenance. CB-5083, a potent and selective p97 inhibitor, is emerging as a transformative tool for dissecting these mechanisms and enabling therapeutic innovation (CB-5083 product_spec).

Mechanism of Action: CB-5083 as a Selective p97 Inhibitor

CB-5083 distinguishes itself by targeting the second ATPase domain (D2) of p97, directly competing with ATP binding and exhibiting an impressive IC50 of 15.4 nM against wild-type p97 (source: product_spec). This high selectivity is critical for minimizing off-target effects while decisively disrupting p97-dependent pathways. Functionally, CB-5083 causes the accumulation of poly-ubiquitinated proteins, blocks proteasomal degradation, and triggers a robust unfolded protein response (UPR) in various human cell lines, including HEK293T, A549, and HCT116. These events collectively induce apoptosis in cancer cells at micromolar concentrations (source: product_spec).

Protocol Parameters

• ATPase inhibition (in vitro) | IC50: 15.4 nM | Human p97 enzyme assays | Establishes potency and selectivity | product_spec
• Cellular apoptosis induction | 1–10 μM | HEK293T, A549, HCT116 | Optimal for screening cancer cell lines | product_spec
• In vivo tumor growth inhibition | 10–20 mg/kg oral, daily | Xenograft mouse models | Effective dosing for tumor suppression | product_spec
• Solubility | ≥20.65 mg/mL (DMSO), ≥4.4 mg/mL (ethanol) | Stock preparation for cell-based and animal studies | Ensures assay reproducibility | product_spec
• Storage | -20°C (solid) | All applications | Maintains compound stability | product_spec
• Assay timing | Use solutions promptly (<24h) | All applications | Prevents loss of activity | workflow_recommendation

CB-5083 in the Context of Protein Homeostasis Disruption

Existing literature extensively details how CB-5083 uniquely enables mechanistic studies of protein homeostasis disruption and endoplasmic reticulum (ER) stress in cancer (see prior advanced applications). Our approach here advances beyond classical protein/lipid interplay, integrating the latest findings on p97’s involvement in genome maintenance—a facet previously underexplored in the context of CB-5083 research.

By inhibiting p97, CB-5083 not only leads to cancer cell apoptosis induction and tumor growth inhibition in xenograft models, but also modulates DNA repair pathways that govern cellular aging and longevity. This dual impact is becoming increasingly relevant as the field recognizes protein homeostasis and genome integrity as converging axes of cellular fate.

Reference Insight: DNA Repair, cGAS, and p97—A New Paradigm

A recent breakthrough study (Chen et al., Science 2025) elucidates a novel mechanism in naked mole-rats, linking p97 function to DNA double-strand break (DSB) repair via cGAS. Unlike in humans and mice, naked mole-rat cGAS features four unique amino acid substitutions that prolong its chromatin retention after DNA damage by attenuating ubiquitination and modulating its interaction with p97. This stabilization enhances the recruitment of key repair factors (FANCI and RAD50), potentiating homologous recombination (HR) repair, reducing cellular senescence, and extending organismal lifespan.

For researchers leveraging p97 inhibitors like CB-5083, this finding is transformative. It suggests that inhibiting p97 not only disrupts protein homeostasis but could selectively modulate DNA repair dynamics—especially HR—by altering cGAS-p97 interactions. Practical assay design should thus account for the possibility that CB-5083 may indirectly affect cellular responses to DNA damage, with implications for both cancer therapy and aging research.

Practical Implications for Assay Design

• Consider monitoring HR repair markers (e.g., RAD50, FANCI recruitment) when using CB-5083 in DNA damage response studies.
• Assess senescence and UPR markers to capture the full spectrum of CB-5083’s effects in model systems.
• Recognize species-specific differences in cGAS-p97 crosstalk—findings in naked mole-rat systems may not directly translate to human cells but illuminate regulatory principles.

Distinctive Applications: Beyond Cancer to Aging and Genome Integrity

While most prior reviews emphasize CB-5083's capacity to induce apoptosis and suppress tumor growth (see MG-132.com summary), this article uniquely focuses on the intersection of protein homeostasis disruption and DNA repair modulation—linking oncology and geroscience. The referenced mechanism, wherein p97 governs the ubiquitination and chromatin retention of cGAS, highlights a novel axis for manipulating cellular lifespan and stress resistance.

For instance, targeting p97 with CB-5083 in preclinical models may not only enhance cancer cell apoptosis but also provide a platform for studying how proteostasis and genome maintenance co-regulate cell fate. This dual approach opens new avenues for drug development, particularly for disorders characterized by both proteotoxic and genotoxic stress.

Comparative Analysis: CB-5083 Versus Alternative Approaches

Current literature, including recent mechanistic reviews, has begun to recognize the importance of targeting both protein and lipid homeostasis using p97 inhibitors. However, few have addressed the emerging interface between p97 inhibition and DNA repair regulation. Our analysis fills this gap by systematically integrating data from cancer biology, proteostasis, and the latest DNA repair research. This holistic perspective enables more strategic use of CB-5083 in research applications that extend beyond traditional cytotoxicity assays.

Why this cross-domain matters, maturity, and limitations

The convergence of protein homeostasis and DNA repair is a frontier in both cancer and aging research. By leveraging CB-5083, researchers can interrogate not just the acute stress responses of tumors but also the underlying mechanisms that determine cellular longevity and resilience to genomic insult. Nonetheless, it is crucial to recognize that the cGAS-p97 dynamics characterized in naked mole-rats represent an evolutionary adaptation; direct translation to human systems requires further validation. The mechanistic principles, however, provide a valuable framework for designing cross-domain studies (Chen et al., Science 2025).

Advanced Workflow Recommendations for CB-5083

Given CB-5083’s oral bioavailability and high solubility in DMSO, it is well-suited for both in vitro and in vivo studies targeting multiple myeloma research and solid tumor models. Users should prepare fresh solutions before use, avoid long-term storage in solution, and optimize dosing based on the specific cell line or animal model under investigation (product_spec).

Key Workflow Suggestions

• For apoptosis induction and tumor suppression, use 1–10 μM in cell culture and 10–20 mg/kg in mouse xenografts (product_spec).
• Monitor UPR and DNA repair markers to capture both canonical and emerging mechanisms of action.
• Pair CB-5083 with assays for senescence and chromatin binding proteins, following recent insights into cGAS-p97 dynamics.
• For reproducibility, always reference the lot-specific COA from APExBIO and document solution preparation methods.

Conclusion and Future Outlook

CB-5083 is not only a benchmark tool for p97 inhibition and cancer cell apoptosis induction but is now positioned at the vanguard of research into how protein homeostasis disruption interplays with DNA repair and cellular longevity. The recent mechanistic advances in naked mole-rat cGAS-p97 interaction (Chen et al., Science 2025) provide a powerful conceptual bridge for researchers to design next-generation assays that span oncology, aging, and genome stability.

As the landscape of protein homeostasis and DNA repair research evolves, the versatility of CB-5083—available from APExBIO—will continue to drive discoveries at the interface of cancer biology and cellular longevity. For those seeking deeper integration of proteostasis and genome integrity in drug discovery or basic science, CB-5083 stands out as an essential, evidence-backed tool.